Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionFoster & Motley Inc
Latest Disclosed Ownership12,702 shares
Latest Disclosed Value $ 1,770
Foster & Motley Inc reports 7.81% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 21, 2026 - Foster & Motley Inc filed a 13F-HR form disclosing ownership of 12,702 shares of Gilead Sciences, Inc. (CH:GILD) valued at $1,770 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 13,778 shares of Gilead Sciences, Inc.. This represents a change in shares of -7.81% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F Gilead Sciences com 375558103 12,702 -1,076 -7.81 2 0.00 0.0913
2026-01-15 2025-12-31 13F Gilead Sciences com 375558103 13,778 -301 -2.14 2 0.00 0.0902
2025-10-23 2025-09-30 13F Gilead Sciences com 375558103 14,079 -519 -3.56 2 0.00 0.0842
2025-07-29 2025-06-30 13F Gilead Sciences com 375558103 14,598 -58 -0.40 2 0.00 0.0935
2025-05-08 2025-03-31 13F Gilead Sciences com 375558103 14,656 4,069 38.43 2 0.1034
2025-01-23 2024-12-31 13F Gilead Sciences com 375558103 10,587 4,718 80.39 1 0.0636
2024-10-30 2024-09-30 13F Gilead Sciences com 375558103 5,869 -138 -2.30 0 0.0312
2024-08-02 2024-06-30 13F Gilead Sciences com 375558103 6,007 53 0.89 0 0.0283
2024-04-18 2024-03-31 13F Gilead Sciences com 375558103 5,954 137 2.36 0 0.0300
2024-02-01 2023-12-31 13F Gilead Sciences com 375558103 5,817 13 0.22 0 0.0350
2023-10-24 2023-09-30 13F Gilead Sciences com 375558103 5,804 63 1.10 0 0.0357
2023-08-08 2023-06-30 13F Gilead Sciences com 375558103 5,741 -107 -1.83 0 0.0342
2023-05-09 2023-03-31 13F Gilead Sciences com 375558103 5,848 153 2.69 0 0.0395
2023-02-09 2022-12-31 13F Gilead Sciences com 375558103 5,695 -377 -6.21 0 -100.00 0.0417
2022-11-04 2022-09-30 13F Gilead Sciences com 375558103 6,072 70 1.17 375 1.08 0.0356
2022-08-09 2022-06-30 13F Gilead Sciences com 375558103 6,002 -299 -4.75 371 -1.07 0.0326
2022-04-28 2022-03-31 13F Gilead Sciences com 375558103 6,301 -255 -3.89 375 -21.22 0.0294
2022-01-25 2021-12-31 13F Gilead Sciences com 375558103 6,556 -107 -1.61 476 2.37 0.0370
2021-10-29 2021-09-30 13F Gilead Sciences com 375558103 6,663 -1,419 -17.56 465 -16.52 0.0387
2021-07-20 2021-06-30 13F Gilead Sciences com 375558103 8,082 1,675 26.14 557 34.54 0.0466
2021-04-26 2021-03-31 13F Gilead Sciences com 375558103 6,407 0 0.00 414 10.99 0.0345
2021-02-01 2020-12-31 13F Gilead Sciences com 375558103 6,407 653 11.35 373 2.47 0.0360
2020-10-19 2020-09-30 13F Gilead Sciences com 375558103 5,754 3 0.05 364 -17.65 0.0429
2020-07-20 2020-06-30 13F Gilead Sciences com 375558103 5,751 2 0.03 442 2.79 0.0553
2020-04-21 2020-03-31 13F Gilead Sciences com 375558103 5,749 -295 -4.88 430 9.41 0.0641
2020-02-05 2019-12-31 13F Gilead Sciences com 375558103 6,044 -162 -2.61 393 0.00 0.0492
2019-10-24 2019-09-30 13F Gilead Sciences com 375558103 6,206 2 0.03 393 -6.21 0.0535
2019-07-17 2019-06-30 13F Gilead Sciences com 375558103 6,204 -499 -7.44 419 -3.90 0.0587
2019-05-08 2019-03-31 13F Gilead Sciences com 375558103 6,703 2 0.03 436 4.06 0.0628
2019-01-30 2018-12-31 13F Gilead Sciences com 375558103 6,701 -103 -1.51 419 -20.19 0.0671
2018-10-31 2018-09-30 13F Gilead Sciences com 375558103 6,804 -486 -6.67 525 1.74 0.0788
2018-07-24 2018-06-30 13F Gilead Sciences com 375558103 7,290 -113 -1.53 516 -7.53 0.0823
2018-05-14 2018-03-31 13F Gilead Sciences com 375558103 7,403 -1,068 -12.61 558 -8.07 0.0909
2018-01-22 2017-12-31 13F Gilead Sciences com 375558103 8,471 -108 -1.26 607 -12.66 0.0970
2017-10-19 2017-09-30 13F Gilead Sciences com 375558103 8,579 -816 -8.69 695 4.51 0.1196
2017-07-31 2017-06-30 13F Gilead Sciences com 375558103 9,395 -498 -5.03 665 -1.04 0.1175
2017-04-24 2017-03-31 13F Gilead Sciences com 375558103 9,893 -2,265 -18.63 672 -22.85 0.1225
2017-01-19 2016-12-31 13F Gilead Sciences com 375558103 12,158 -6,706 -35.55 871 -41.66 0.1667
2016-10-28 2016-09-30 13F Gilead Sciences com 375558103 18,864 -48,483 -71.99 1,493 -73.42 0.2881
2016-08-02 2016-06-30 13F Gilead Sciences com 375558103 67,347 -5,785 -7.91 5,618 -16.37 1.1092
2016-04-20 2016-03-31 13F Gilead Sciences com 375558103 73,132 -561 -0.76 6,718 -9.91 1.3603
2016-01-25 2015-12-31 13F Gilead Sciences com 375558103 73,693 2,477 3.48 7,457 6.79 1.5819
2015-11-09 2015-09-30 13F Gilead Sciences com 375558103 71,216 9,493 15.38 6,983 -3.38 1.5889
2015-08-10 2015-06-30 13F Gilead Sciences com 375558103 61,723 18,874 44.05 7,227 71.87 1.5861
2015-04-16 2015-03-31 13F Gilead Sciences com 375558103 42,849 8,579 25.03 4,205 30.19 0.9232
2015-01-22 2014-12-31 13F Gilead Sciences com 375558103 34,270 20,585 150.42 3,230 121.69 0.7316
2014-10-16 2014-09-30 13F Gilead Sciences com 375558103 13,685 10,388 315.07 1,457 433.70 0.3383
2014-07-25 2014-06-30 13F Gilead Sciences com 375558103 3,297 3,297 273 0.0630
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.